Firms

Cambridge Innovation Capital
Cambridge Innovation Capital (CIC) is a Cambridge venture investment platform backing deep technology and life sciences, including artificial intelligence, quantum computing, photonics, semiconductors, robotics, genomics, gene therapy and neuroscience. It has a close relationship with the University of Cambridge and supports companies emerging from the regional research ecosystem. The website operator/parent Cambridge Innovation Capital Limited, company08243718, was incorporated October8,2012 and formerly used PLC; the distinct regulated subsidiary Cambridge Innovation Capital Manager Limited, company12002307, was incorporated May17,2019 and is FCA-authorised under FRN918898. This retained investor profile represents the published CIC investment platform, with legal parent and manager distinguished rather than treating every group entity as a cash subscriber. Its published team includes investment and operating staff, board directors, an advisory panel, specialist advisers, and current or explicitly former entrepreneurs in residence. FundII raised GBP225M in2022; its USD300M equivalent is not a second raise. The GBP100M Opportunity Fund was launched inFebruary2025 with primary-confirmed GBP20M British Patient Capital commitment and GBP15M Aviva investment; a final GBP100M cash close is not asserted. Legacy FundI emerged from corporate shareholder capital, with cumulative commitments and actual capital calls distinguished from a traditional external LP closing. AUM, portfolio co-investment and fund management transfers are not fresh closed cash. Existing institutional and individual investment records are preserved.
- Founded
- —
- Type
- Venture capital






































































